Treatment with α-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading

Effective treatment of diabetic sensorimotor polyneuropathy remains a challenge. To assess the efficacy and safety of α-lipoic acid (ALA) over 20 weeks, we conducted a multicenter randomized withdrawal open-label study, in which 45 patients with type 2 diabetes and symptomatic polyneuropathy were in...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Alcala, Hector, Santos Vichido, Celia Isabel, Islas Macedo, Silverio, Genestier-Tamborero, Christelle Nathalie, Minutti-Palacios, Marissa, Hirales Tamez, Omara, García, Carlos, Ziegler, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539458/
https://www.ncbi.nlm.nih.gov/pubmed/26345602
http://dx.doi.org/10.1155/2015/189857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539458/
https://www.ncbi.nlm.nih.gov/pubmed/26345602
http://dx.doi.org/10.1155/2015/189857

Ejemplares similares